# AXOS and Microbial Metabolites in CKD

> **NCT02141815** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 40 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Arabinoxylan-oligosaccharides
- **DIETARY_SUPPLEMENT:** Maltodextrine

## Key facts

- **NCT ID:** NCT02141815
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141815, "AXOS and Microbial Metabolites in CKD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02141815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*